医療関係者様へ
2018年発表論文
2018.05.06
2018年に当教室で発表した和文原著です。
| 題名（論文名） | 著者 | 掲載雑誌 |
|---|---|---|
| 【腎泌尿器診療の国際標準】 去勢抵抗性前立腺がん治療の国際比較 | 泉浩二、溝上敦 | 腎臓内科・泌尿器科 2018; 7(1): 50-55. |
| 尿管皮膚瘻からBCGを尿管内へ注入した1例 |
加藤 佑樹, 泉 浩二, 野原 隆弘, 重原 一慶, 角野 佳史, 溝上 敦 |
泌尿器外科2018; 31(3): 321-324. |
| 高齢者における性機能障害－アンドロゲン補充療法の意義． |
重原一慶、溝上敦 |
腎臓内科・泌尿器科2018; 8(3): 279-84. |
| 最新調査研究報告 (その1)HPV自己採取による郵送検査を用いた性の健康医学財団による全国調査の中間報告. |
北村 唯一, 重原 一慶, 鈴木 基文. |
性の健康 2018; 17: 16-18. |
| 経尿道的にホルミウム・ヤグレーザーを用いた治療が奏効した尿道コンジローマの1例 |
坂本次郎、重原一慶、中嶋一史、飯島将司、川口昌平、野原隆弘、泉浩二、角野佳史、溝上敦 |
日性感染症学会誌2018; doi:10.24775/jjsti.29.1.123 |
| 【腎泌尿器診療の国際標準】 去勢抵抗性前立腺がん治療の国際比較 |
泉浩二、溝上敦 |
腎臓内科・泌尿器科2018: 7(1): 50-55 |
|
前立腺癌骨微小環境におけるCCL5による癌進展機構 |
浦田 聡子, 泉 浩二, 平塚 薫, 重原 一慶, 岩本 大旭, 門本 卓, 牧野 友幸, 内藤 伶奈人, 角野 佳史, 溝上 敦, Lin Wen-Jye, 成本 一隆 |
西日本泌尿器科2018; 80(10): 510-516. |
|
【まるごと 見逃してはならない泌尿器科疾患の初期症状】 泌尿器がん・腫瘍 前立腺がん
|
中嶋 一史, 溝上 敦 |
Uro-Lo: 泌尿器Care & Cure 2018: 23(3): 275-278. |
2018年に当教室で発表し英文原著です。
| 題名（論文名） | 著者 | 掲載雑誌 |
|---|---|---|
| Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines. | Machioka K, Izumi K, Kadono Y, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Keller ET, Zhang J, Mizokami A. | Oncotarget. 2018 ;9(22):16185-16196. |
| Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study. | Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators. | Int J Urol. 2018; 25(5):492-499. |
| Significance of Perioperative Chemotherapy in Squamous Cell Carcinoma of the Upper and Lower Urinary Tract. | Makino T, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Naito R, Kadono Y, Mizokami A. | Anticancer Res. 2018; 38(4):2241-2245. |
| Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells |
Takezawa Y, Izumi K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Kadono Y, Keller ET, Zhang J, Mizokami A. |
Anticancer Res. 2018 ; 38(4):2045-2055. |
| Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation. |
Maolake A, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Makino T, Naito R, Shigehara K, Kadono Y, Hiratsuka K, Wufuer G, Nastiuk KL, Mizokami A. |
Cancer Sci. 2018; 109(5):1524-1531. |
| Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1). |
Ueno S, Kitagawa Y, Onozawa M, Hinotsu S, Akaza H, Mizokami A, Namiki M. |
Prostate Int. 2018 ;6(1):7-11. |
| Investigating the mechanism underlying urinary continence recovery after radical prostatectomy: effectiveness of a longer urethral stump to prevent urinary incontinence. |
Kadono Y, Nohara T, Kawaguchi S, Naito R, Urata S, Nakashima K, Iijima M, Shigehara K, Izumi K, Gabata T, Mizokami |
BJU Int. 2018;122(3):456-462 |
| C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment. |
Urata S, Izumi K, Hiratsuka K, Maolake A, Natsagdorj A, Shigehara K, Iwamoto H, Kadomoto S, Makino T, Naito R, Kadono Y, Lin WJ, Wufuer G, Narimoto K, Mizokami A. |
Cancer Sci. 2018; 109(3):724-731. |
| Editorial Comment to Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement. |
Shigehara K, Mizokami A. |
Int J Urol. 2018; 21(2):99-105. |
| Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea. |
Shigehara K, Konaka H, Sugimoto K, Nohara T, Izumi K, Kadono Y, Namiki M, Mizokami A. |
Aging Male. 2018;21(2):99-105. |
| Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomized controlled trial (EARTH study). |
Shigehara K, Konaka H, Izumi K, Kitagawa Y, Kadono Y, Koh E, Iwamoto T, Mizokami A, Namiki M. |
Andrologia 2018 Feb;50(1). |
| Risk factors for human papillomavirus detection in urine samples of heterosexual men visiting urological clinics in Japan. |
Nakashima T, Shigehara K, Kitamura T, Yaegashi H, Shimamura M, Kawaguchi S, Izumi K, Kadono Y, |
J Infect Chemother. 2018; 24(9):713-717. |
| Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy. | Kadono Y, Nohara T, Kawaguchi S, Sakamoto J, Makino T, Nakashima K, Iijima M, Shigehara K, Izumi K, Mizokami A. | Andrology. 2018;
|
| Overexpression of p54nrb/NONO induces differential EPHA6 splicing and contributes to castration-resistant prostate cancer growth. | Iwamoto H, Yamamoto R, Osawa T, Sasaki Y, Yamamoto S, Anai M, Izumi K, Matsumura Y, Sakai J, Aburatani H, Mizokami A, Kodama T, Tanaka T | Oncotarget. 2018 ;9(12):10510-10524 |
| Long-term persistence of human papillomavirus in the skin of the glans penis of elderly men above 80 years of age. | Kitamura T, Suzuki M, Koyama Y, Shigehara K. | Int J STD AIDS. 2018; 29(6):552-556. |
|
Predictors of persistent stress urinary incontinence after transvaginal mesh repair. |
Kawaguchi S, Narimoto K, Urata S, Takeyama M, Kadono Y, Mizokami A. | BMC Womens Health. 2018;18(1):174. |
| Reiter’s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases | Nakagawa T, Shigehara K, Naito R, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Kitagawa Y, Izumi K, Kadono Y, Mizokam A | Int Cancer Conf J. 2018; 7(4): 148–151 |
| 5′-Chloro-2,2′-dihydroxychalcone and related flavanoids as treatments for prostate cancer. | Saito Y, Mizokami A, Tsurimoto H, Izumi K, Goto M, Nakagawa-Goto K. |
|
| Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor. | Iwamoto H, Izumi K, Natsagdorj A, Makino T, Nohara T, Shigehara K, Kadono Y, Mizokami A. | In Vivo. 2018; 32(4):899-903. |
| Editorial comment to Predictors of biochemical recurrence after retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up of 26 months | Kadono Y. | Int J Urol. 2018; 25(12):1014 |
| CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells. | Natsagdorj A, Izumi K, Hiratsuka K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Shigehara K, Kadono Y, Lin WJ, Maolake A, Mizokami A. | Cancer Sci. 2018; 110(1):279-288. |
|
Gonadal function and testicular histology in males with Prader-Willi syndrome. |
|
|